The Nomination Committee in Polygiene AB (publ) has consisted of Mats Jacobson, representing Jonas Wollin, Mette Gross, representing Lennart Holm, Markus Lindqvist, representing Aktia Fund Management, and the Chairman of the board, Jonas Wollin. Mats Jacobson has been the Chairman of the Nomination Committee.
The Nomination Committee proposes that the annual shareholders’ meeting on 17 May 2019 resolves to re-elect Jonas Wollin, Martin Kössler and Daniel Röme as ordinary board members, and to elect Ebba Fåhraeus and Håkan Lagerberg as new ordinary board members. The Nomination Committee proposes re-election of Jonas Wollin as Chairman of the board.
The present board members Lennart Holm, Jonas Sjögren and Daniel Oelker have declined re-election.
Ebba Fåhraeus, born 1963, is an analytical and pro-active business developer with international experience in the areas of marketing and business development at a strategic level in listed companies. With a degree in Business Administration from Stockholm School of Economics as a foundation, Ebba Fåhraeus has extensive experience from B2B as well as B2C. She is a board member of a number of small and medium-sized companies, of which the majority are within the Life Science sector, where she contributes with her competence within growth strategies, business development and communication. Ebba Fåhraeus is also a member of the Faculty of Medicine’s board of Lund University. Ebba Fåhraeus holds no shares in the company. Ebba Fåhraeus is considered to be independent in relation to the company and its senior management as well as in relation to major shareholders.
Håkan Lagerberg, born 1968, has extensive experience from leading positions in private and public companies, inter alia within international sales, marketing and negotiation, both operationally and strategically. Håkan Lagerberg also has reputable market and investor contacts. Håkan Lagerberg’s education include international Master of Laws degree (LLM) from Lund University and International Trade Law from the University of Torino in Italy. Håkan Lagerberg is currently CEO and board member of Swedencare AB (publ), listed on Nasdaq First North since 2016. Håkan Lagerberg is inter alia Chairman of the board of One CC AB and board member of HAOLAG AB and Mastan AB. Håkan Lagerberg holds indirectly through company 1,485,098 shares in the company. Håkan Lagerberg is considered to be independent in relation to the company and its senior management as well as in relation to major shareholders.
Information about the board members proposed for re-election can be found in the Annual Report and at the company’s website, www.polygiene.com/ir.
The Nomination Committee’s other proposals to the annual shareholders’ meeting will be presented in connection with the notice convening the annual shareholders’ meeting.
This information was submitted for publication, through the agency of the contact person set out below, at April 15, 2019, at 13:00 CET.
